<DOC>
	<DOCNO>NCT02615665</DOCNO>
	<brief_summary>The long-term outcome patient resect colorectal liver metastasis ( CLM ) neoadjuvant chemotherapy ( CHT ) depend several tumoral non-tumoral factor , immune response tumor CHT . The aim study investigate impact pathological immunological response patient undergo liver resection CLM CHT regard long-term outcome .</brief_summary>
	<brief_title>Intratumoral CD3+ NKp46+ Cells Colorectal Liver Metastases</brief_title>
	<detailed_description>The immunoreactivity CD3+ NKp46+ cell inside tumor , border tumor normal liver , inside normal liver test computer-assisted image analyse patient undergo liver resection CLM 2005 2013 preoperatively treat oxaliplatin irinotecan without bevacizumab cetuximab . The survival assess relation several prognostic factor immunoreactivity .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>histological proven colorectal liver metastases complete clinical , surgical , pathological followup data nonradical surgery incomplete clinical , surgical , pathological followup data</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>NK-cells</keyword>
	<keyword>T-cells</keyword>
</DOC>